Experimental oral administration of canine adenovirus (type 2) to raccoons (Procyon lotor).
Canine adenovirus type 2 (CAV2) has been proposed for recombinant vaccines to control rabies in wild animals. To evaluate the suitability of CAV2 as a safe vector for the genetically engineered vaccines, seven wild-caught raccoons (three males and four females) were administered CAV2 per os. Two of the animals were euthanatized on each of post-infection days 3, 6, and 14, and one was euthanatized on day 21. Two other control raccoons (a male and a female) were also euthanatized on day 21. Microscopic pulmonary lesions of multifocal necrotizing bronchiolitis with basophilic intranuclear inclusions were seen in 3/4 raccoons euthanatized on post-infection days 3 and 6. Ultrastructural examination of lungs with pulmonary lesions revealed hexagonal viral particles characteristic of adenoviruses. CAV2 is potentially pathogenic for raccoons, and this susceptibility should be of concern to developers of recombinant vaccines who intend to use CAV2 as a vaccine vector.
Hamir
A N
AN
Laboratory of Large Animal Pathology, University of Pennsylvania, Kennett Square 19348.
Raju
N
N
Rupprecht
C E
CE
D000256:Adenoviridae / Q000276:immunology*; D000284:Administration, Oral; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D005260:Female; D008168:Lung / Q000473:pathology*; D008297:Male; D011821:Raccoons / Q000276:immunology; D014765:Viral Vaccines / Q000633:toxicity*
D000914:Antibodies, Viral; D014765:Viral Vaccines